2SU-29682-00356
3 vaccinations
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 145 / NY
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Registered in v-safe
-
2021-01-30
Dose 2 — Pfizer-BioNTech
-
2021-01-30
Health check-in — day 0, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-30
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-02-01
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Good · Fatigue or tirednessFree text: Mental fogginessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
- 2021-02-04
- 2021-08-02
-
2021-10-15
Dose 3 — Pfizer-BioNTech
- 2022-01-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-30 | priority 2/3 |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Mental fogginess
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release